Quartesian Achieves ISO 9001:2015 and ISO/IEC 27001:2013 Certifications
Princeton, NJ – January 6, 2021 – Quartesian, a multinational Clinical Research Organization (CRO) serving the biopharmaceutical and medical device
Quartesian Announces Amyndas Partnership for COVID-19 Clinical Trial
PRINCETON, N.J., June 16, 2020 /PRNewswire/ — Quartesian, a multinational Clinical Research Organization (CRO) serving the biopharmaceutical and medical device industries, today announced
Quartesian Announces Veeva Partnership for Clinical Data Management
Princeton, NJ – May 27, 2020 – Quartesian, a multinational Clinical Research Organization (CRO) serving the biopharmaceutical and medical device
Collecting Clinical Data in a Post-COVID Environment
Prediction: In 10 years, clinical trials will be nearly paperless. And clinical trial historians will note that the Coronavirus pandemic
Announcing Quartesian’s Strategic Partnership with ILIKOS
With increasing drug development costs and complexity, meaningful clinical partnerships can help sponsors establish their most efficient and cost-effective processes.
Customize Your Clinical Metadata Repositories and Statistical Computing Environments
WEBINAR Customize Your Clinical Metadata Repositories and Statistical Computing Environments Watch our webinar to learn how to manage the growing
FDA & EMA Updates
The start of the new year brought some changes for the FDA and EMA. In an effort to keep you
Quartesian Official Communication on COVID-19/Coronavirus
March 18, 2020 Hello Everyone, This is to inform you that Quartesian is closely tracking the Coronavirus (COVID-19) pandemic outbreak
Quartesian’s 2019 performance yields record revenue and growth
Throughout 2019, Quartesian continues to gain momentum with strong uptake rates for new services and large contract growth. With over
Quartesian Announces New Pharmacovigilance Offering
Quartesian is excited to announce a new offering: a suite of clinical trial data pharmacovigilance services. Our services for clinical
Quartesian Enters Agreement with Medrio to Gain Full Enterprise Access
Quartesian has entered a multi-year agreement with Medrio, a leading eClinical technology provider, to provide even more high-quality data to
Quartesian Partnership Gives Midsize CRO a Competitive Edge
CRO Gives Sponsors the Best of Both Worlds By Partnering with Quartesian The Challenge: Offer Midsize CRO Benefits With Large
